Gaucher Disease Types I and III Responded Well to Substrate Reduction Therapy Using Eliglustat.

Intern Med · 2023 · PMC10641180 · PMID 36889706

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

After the switch, there was no progression of hemoglobin levels or platelet count decline, and serum ACE levels showed a trend toward improvement.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.